Risk sharing scheme
20 Feb 2003
'It's over a year since the scheme was announced to provide disease modifying drugs on the NHS. Setting up the scheme has proved a challenge but come April and the new financial year, things around the country should start to pick up.
Risk Sharing - it's an odd name that needs some explanation. Under the scheme, people with MS who meet the eligibility criteria set out by the Association of British Neurologists can obtain the drugs beta interferon and glatiramer acetate - Avonex, Rebif, Betaferon, Copaxone -? on the NHS. So who takes the risk?'
This is an extract from an MS Matters article. Download the entire article below.
The Complete 'Risk Sharing' Article
The MS Society can tell you who to contact in your area about the Risk Sharing scheme.
This is an extract from an MS Matters article. Download the entire article below.
The Complete 'Risk Sharing' Article
The MS Society can tell you who to contact in your area about the Risk Sharing scheme.
- To find out who to contact in your area, telephone the Policy & Campaigns Team on 020 8438 0829 or email campaigns@mssociety.org.uk
- If you haven't already registered for regular updates on Risk Sharing and MS Drugs, click on the 'Sign Up for Updates' link at the top of this page.
The article was first published in January-February 2003 in the MS Society's magazine for members, MS Matters. To receive MS Matters, call the MS National Centre on 020 8438 0700
BACK TO TOP
